MaaT Pharma (Microbiota as a Therapy) is a French biotech start-up.
MaaT Pharma has raised $10.6M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in November 2025.
MaaT Pharma's investors include European Investment Bank, Bpifrance, Seventure Partners, Invus, Crédit Mutuel Innovation.
MaaT Pharma is headquartered in Lyon, France.
MaaT Pharma (Microbiota as a Therapy) is a French biotech start-up.
MaaT Pharma is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"MaaT Pharma — Funding & Investors." VCBacked, November 13, 2025, https://www.vcbacked.co/company/maat-pharma. Accessed July 21, 2026.
VCBacked. (2025). MaaT Pharma — Funding & Investors. Retrieved July 21, 2026, from https://www.vcbacked.co/company/maat-pharma
{{cite web |title=MaaT Pharma — Funding & Investors |url=https://www.vcbacked.co/company/maat-pharma |website=VCBacked |access-date=July 21, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated